Table 2 This table presents the mean change and 95% confidence interval for each perfusion statistic over each ROI for the pre/post verapamil dataset.
From: Computational methods for visualizing and measuring verapamil efficacy for cerebral vasospasm
\({\Delta }\)AT (s) | \({\Delta }\)TTP (s) | \({\Delta }\)TTD (s) | \({\Delta }\)MTT (s) | |
|---|---|---|---|---|
AP MCA | − 0.60 ± 0.48* | − 1.2 ± 1.1* | − 0.008 ± 0.3 | − 0.52 ± 0.87 |
LAT MCA | − 0.30 ± 0.47 | − 0.37 ± 1.1 | 0.17 ± 0.59 | 0.07 ± 0.91 |
AP ACA | − 0.66 ± 0.59* | − 1.6 ± 1.3* | − 0.0008 ± 0.35 | − 1.1 ± 1.0* |
LAT ACA | − 0.29 ± 0.52 | − 0.31 ± 1.2 | 0.11 ± 0.64 | 0.07 ± 0.91 |
AP basilar | − 0.70 ± 2.0 | 0.45 ± 2.2 | 0.37 ± 0.79 | -2.1 ± 7.0 |
LAT basilar | 0.12 ± 1.6 | 1.4 ± 3.4 | 0.49 ± 0.87 | 2.5 ± 3.0 |
